# Ranolazine and Microvascular Angina by PET in the Emergency Department

> **NCT02052011** · PHASE4 · COMPLETED · sponsor: **Yale University** · enrollment: 31 (actual)

## Conditions studied

- Microvascular Angina

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02052011
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02052011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02052011, "Ranolazine and Microvascular Angina by PET in the Emergency Department". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02052011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*